CB
IONS icon

Commerce Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Commerce Bank’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$613K Buy
8,165
+54
+0.7% +$4.26K ﹤0.01% 875
2025
Q4 		$642K Buy
8,111
+504
+7% +$38K ﹤0.01% 796
2025
Q3 		$498K Hold
7,607
– – ﹤0.01% 874
2025
Q2 		$301K Buy
7,607
+332
+5% +$10.9K ﹤0.01% 1036
2025
Q1 		$219K Sell
7,275
-6,309
-46% -$207K ﹤0.01% 1115
2024
Q4 		$475K Sell
13,584
-63,969
-82% -$2.39M ﹤0.01% 878
2024
Q3 		$3.11M Buy
77,553
+1,211
+2% +$56.3K 0.02% 416
2024
Q2 		$3.64M Sell
76,342
-6,091
-7% -$250K 0.02% 365
2024
Q1 		$3.57M Buy
82,433
+15,416
+23% +$735K 0.02% 388
2023
Q4 		$3.39M Sell
67,017
-10,630
-14% -$509K 0.02% 385
2023
Q3 		$3.52M Sell
77,647
-10,635
-12% -$439K 0.03% 345
2023
Q2 		$3.62M Buy
88,282
+80,736
+1,070% +$3.1M 0.03% 346
2023
Q1 		$270K Sell
7,546
-196
-3% -$7.36K ﹤0.01% 1020
2022
Q4 		$292K Buy
7,742
+311
+4% +$13.1K ﹤0.01% 983
2022
Q3 		$329K Hold
7,431
– – ﹤0.01% 913
2022
Q2 		$275K Sell
7,431
-567
-7% -$21.4K ﹤0.01% 980
2022
Q1 		$296K Buy
+7,998
New +$262K ﹤0.01% 1010
2021
Q3 		– Sell
-6,291
Closed -$251K – 1171
2021
Q2 		$251K Sell
6,291
-185
-3% -$7.25K ﹤0.01% 1064
2021
Q1 		$291K Buy
6,476
+323
+5% +$18K ﹤0.01% 989
2020
Q4 		$348K Sell
6,153
-138
-2% -$6.88K ﹤0.01% 898
2020
Q3 		$299K Sell
6,291
-1,425
-18% -$79.2K ﹤0.01% 858
2020
Q2 		$455K Buy
7,716
+1,023
+15% +$56.9K ﹤0.01% 700
2020
Q1 		$316K Buy
+6,693
New +$373K ﹤0.01% 742

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commerce Bank's IONS Position: Q1 2026 in Review

Commerce Bank increased its Ionis Pharmaceuticals (IONS) stake by 0.67% in Q1 2026, buying an estimated $4.26K and bringing the position to 8,165 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #875.

Commerce Bank first reported a position in IONS in Q1 2020 and has held it in 23 quarters since. The position peaked at $3.64M in Q2 2024. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Commerce Bank held 8,165 shares of Ionis Pharmaceuticals worth $613K as of Q1 2026.
  • Commerce Bank bought 54 Ionis Pharmaceuticals shares in Q1 2026, an estimated $4.26K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q1 2026, its #875 holding.
  • Commerce Bank first reported a position in Ionis Pharmaceuticals in Q1 2020 and has held it in 23 quarters since.
  • Commerce Bank's Ionis Pharmaceuticals position peaked at $3.64M in Q2 2024.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.